In patients with severe fibromyalgia, rozanolixizumab may reduce the impact of the condition on health and function but may ...

Patients with idiopathic pulmonary fibrosis who train by cycling one leg at a time during rehabilitation gain more exercise ...

Nitasha Sarswat, MD, hopes emerging ATTR-CM data will reshape how clinicians identify, monitor, and personalize care for ...

The agency’s backing could potentially increase the use of this first-to-be-approved nonsurgical PDT option in treating basal ...

Among those aged 12-17 years, treated patients showed improvement in eyebrows and eyelashes as well as scalp regrowth.

New trial data in melanoma and early findings in head and neck cancer are advancing individualized vaccines, while questions ...

Researchers evaluate whether negative margins < 2 mm are linked to higher ipsilateral recurrence risk than margins ≥ 2 mm after breast-conserving surgery for ductal carcinoma in situ.

It looks like me, but the voice wasn’t me.’ New Orleans doctor can’t shut down fake look-a-like video hawking supplements.

This marks the third ccRCC approval for the hypoxia-inducible factor-2-alpha inhibitor belzutifan. Its previous approvals ...

Carmen Rubio Rodríguez, MD, PhD, is working to close gaps in access to radiation therapy that continue to separate patients ...

New research published in The BMJ highlights important differences in thrombotic risks associated with different forms of menopausal hormone therapy (MHT). In a nationwide Danish study, oral MHT was ...

Today's FDA approval of tavapadon makes it the first selective D1/D5 receptor agonist for the treatment of adults with Parkinson's disease.